Eva Marina Schmidt

1.5k total citations
32 papers, 1.1k citations indexed

About

Eva Marina Schmidt is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Eva Marina Schmidt has authored 32 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 8 papers in Oncology and 6 papers in Epidemiology. Recurrent topics in Eva Marina Schmidt's work include Receptor Mechanisms and Signaling (10 papers), Liver Disease Diagnosis and Treatment (5 papers) and Cancer Cells and Metastasis (5 papers). Eva Marina Schmidt is often cited by papers focused on Receptor Mechanisms and Signaling (10 papers), Liver Disease Diagnosis and Treatment (5 papers) and Cancer Cells and Metastasis (5 papers). Eva Marina Schmidt collaborates with scholars based in Hungary, Germany and Sweden. Eva Marina Schmidt's co-authors include F. W. Schmidt, Béla Kiss, Zsolt Szombathelyi, György Domány, István Gyertyán, I. Laszlovszky, Thomas Kirchner, Éva Ágai-Csongor, David Horst and Attila Horváth and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and The Journal of Experimental Medicine.

In The Last Decade

Eva Marina Schmidt

31 papers receiving 1.0k citations

Peers

Countries citing papers authored by Eva Marina Schmidt

Since Specialization

Citations

This map shows the geographic impact of Eva Marina Schmidt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Marina Schmidt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Marina Schmidt more than expected).

Fields of papers citing papers by Eva Marina Schmidt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Marina Schmidt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Marina Schmidt. The network helps show where Eva Marina Schmidt may publish in the future.

Co-authorship network of co-authors of Eva Marina Schmidt

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Marina Schmidt. A scholar is included among the top collaborators of Eva Marina Schmidt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Marina Schmidt. Eva Marina Schmidt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Convergent cross-species pro-cognitive effects of RGH-235, a new potent and selective histamine H3 receptor antagonist/inverse agonist 2021 ·European Journal of Pharmacology ·Zsolt Némethy, Béla Kiss, (unknown), Paul L. Chazot, (unknown), Attila Tóth, László Détári, Eva Marina Schmidt, András Czurkó, (unknown), (unknown), István Hernádi, (unknown), E. Sylvester Vizi, (unknown), Sándor Mahó, Viktor Román, Balázs Lendvai, György Lévay	2
2	In vivo effects of chemotherapy on oncogenic pathways in colorectal cancer 2019 ·Cancer Science ·(unknown), Eva Marina Schmidt, (unknown), Gerald Bastian Schulz, Thomas Kirchner, David Horst	11
3	PBX3 Is Part of an EMT Regulatory Network and Indicates Poor Outcome in Colorectal Cancer 2018 ·Clinical Cancer Research ·(unknown), Markus Kaller, Eva Marina Schmidt, Cristina Blaj, Tobias S. Schiergens, Jutta Engel, Andreas Jung, Heiko Hermeking, Thomas G. P. Grünewald, Thomas Kirchner, David Horst	40
4	Targeting tumor cell plasticity by combined inhibition of NOTCH and MAPK signaling in colon cancer 2018 ·The Journal of Experimental Medicine ·Eva Marina Schmidt, (unknown), Cristina Blaj, Christian P. Schaaf, Stefan Krebs, Helmut Blum, Heiko Hermeking, Andreas Jung, Thomas Kirchner, David Horst	28
5	Oncogenic Effects of High MAPK Activity in Colorectal Cancer Mark Progenitor Cells and Persist Irrespective of RAS Mutations 2017 ·Cancer Research ·Cristina Blaj, Eva Marina Schmidt, (unknown), Heiko Hermeking, Andreas Jung, Thomas Kirchner, David Horst	57
6	Multicolor lineage tracing reveals clonal architecture and dynamics in colon cancer 2017 ·Nature Communications ·(unknown), Eva Marina Schmidt, Cristina Blaj, Heiko Hermeking, Andreas Jung, Thomas Kirchner, David Horst	33
7	ADNP Is a Therapeutically Inducible Repressor of WNT Signaling in Colorectal Cancer 2016 ·Clinical Cancer Research ·Cristina Blaj, (unknown), Eva Marina Schmidt, (unknown), (unknown), Thomas Fröhlich, Georg J. Arnold, Stefan Krebs, Helmut Blum, Heiko Hermeking, Andreas Jung, Thomas Kirchner, David Horst	27
8	Virtual fragment screening on GPCRs: A case study on dopamine D3 and histamine H4 receptors 2014 ·European Journal of Medicinal Chemistry ·Márton Vass, Eva Marina Schmidt, (unknown), György M. Keserű	39
9	Identification of Novel Histamine H4 Ligands by Virtual Screening on Molecular Dynamics Ensembles 2014 ·Molecular Informatics ·Róbert Kiss, Balázs Jójárt, Eva Marina Schmidt, Béla Kiss, György M. Keserű	7
10	Expression of progerin in aging mouse brains reveals structural nuclear abnormalities without detectible significant alterations in gene expression, hippocampal stem cells or behavior 2014 ·Human Molecular Genetics ·Jean‐Ha Baek, Eva Marina Schmidt, Nikenza Viceconte, (unknown), Karin Pernold, (unknown), Fred W. van Leeuwen, Nico P. Dantuma, Peter Damberg, Kjell Hultenby, Brun Ulfhake, Enrico Mugnaini, Björn Rozell, Maria Eriksson	31
11	Expression of the Hutchinson-Gilford Progeria Mutation during Osteoblast Development Results in Loss of Osteocytes, Irregular Mineralization, and Poor Biomechanical Properties 2012 ·Journal of Biological Chemistry ·Eva Marina Schmidt, Ola Nilsson, Antti Koskela, Juha Tuukkanen, Claes Ohlsson, Björn Rozell, Maria Eriksson	36
12	Discovery of cariprazine (RGH-188): A novel antipsychotic acting on dopamine D3/D2 receptors 2012 ·Bioorganic & Medicinal Chemistry Letters ·Éva Ágai-Csongor, György Domány, (unknown), János Galambos, (unknown), György M. Keserű, István Greiner, I. Laszlovszky, Anikó Gere, Eva Marina Schmidt, Béla Kiss, Mónika Vastag, Károly Tihanyi, Katalin Sághy, Judit Laszy, István Gyertyán, (unknown), (unknown), Margit Kapás, Zsolt Szombathelyi	74
13	Cariprazine (RGH-188), a Dopamine D3 Receptor-Preferring, D3/D2 Dopamine Receptor Antagonist–Partial Agonist Antipsychotic Candidate: In Vitro and Neurochemical Profile 2010 ·Journal of Pharmacology and Experimental Therapeutics ·Béla Kiss, Attila Horváth, Zsolt Némethy, Eva Marina Schmidt, I. Laszlovszky, (unknown), Károly Fazekas, (unknown), Szabolcs Orosz, István Gyertyán, Éva Ágai-Csongor, György Domány, Károly Tihanyi, Nika Adham, Zsolt Szombathelyi	290
14	Aspartic acid scaffold in bradykinin B1 antagonists 2009 ·Journal of Peptide Science ·(unknown), (unknown), Ferenc Bogár, Botond Penke, Róbert Kiss, Krisztina Szalai, Eva Marina Schmidt, (unknown), György M. Keserű	2
15	RGH-188, a d3/d2 dopamine receptor antagonist/partial agonist atypical antipsychotic candidate 2008 ·European Psychiatry ·I. Laszlovszky, Béla Kiss, István Gyertyán, (unknown), Nicholas Seneca, Eva Marina Schmidt, Zsolt Némethy, (unknown), Katalin Sághy, Judit Laszy, (unknown), György Németh, Zsolt Szombathelyi	3
16	Synthesis and neuropharmacological evaluation of 2-aryl- and alkylapomorphines 2008 ·Bioorganic & Medicinal Chemistry ·(unknown), Béla Kiss, Eva Marina Schmidt, István Greiner, Sándor Berényi	18
17	Subnanomolar dopamine D3 receptor antagonism coupled to moderate D2 affinity results in favourable antipsychotic-like activity in rodent models: I. neurochemical characterisation of RG-15 2008 ·Naunyn-Schmiedeberg s Archives of Pharmacology ·Béla Kiss, I. Laszlovszky, Attila Horváth, Zsolt Némethy, Eva Marina Schmidt, (unknown), Károly Fazekas, István Gyertyán, Éva Ágai-Csongor, György Domány, Zsolt Szombathelyi	58
18	Effects of EGIS-7625, a Selective and Competitive 5-HT2B Receptor Antagonist 2003 ·Cardiovascular Drugs and Therapy ·Anikó Kovács, István Gacsályi, (unknown), Eva Marina Schmidt, (unknown), (unknown), (unknown), Jean A. Boutin, (unknown), (unknown), (unknown), Michael Spedding, Gábor Szénási	6
19	Studies of liver function and structure in patients with gallstones before and during treatment with chenodeoxycholic acid. 1975 ·PubMed ·Hans Fromm, (unknown), (unknown), Eva Marina Schmidt, (unknown)	17
20	Newer diagnostic tests in liver disease. 1961 ·PubMed ·(unknown), (unknown), Eva Marina Schmidt	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact